Atlas Trials

A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis

Clinical trial NCT05095246 · WITHDRAWN

Trial details

NCT number
NCT05095246
Sponsor
Krystal Biotech, Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2022-03-08
Primary completion
2024-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.